Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma

NCT ID: NCT02436070

Last Updated: 2017-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

195 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

BACKGROUND Asthma is a prevalent and troublesome pediatric condition. In 2013, Emergency Department (ED) providers treated over 3,500 cases of asthma-related complaints at Children's Hospitals and Clinics of Minnesota. Pediatric ED visits for asthma exceeds billions of dollars annually when including direct cost and lost productivity. Many of these visits and resultant costs are avoidable. Patients with well-controlled asthma do not typically exhibit these patterns, while patients with poorly controlled asthma show patterns of increased utilization of healthcare resources and lower quality of life. Evidence suggests that a text message reminder and educational program might positively influence pediatric asthma care practices.

RESEARCH QUESTION Does a targeted ED based text message intervention program improve outpatient follow-up and routine preventive care in pediatric asthma patients?

METHODS Study subjects will be block randomized based on age and insurance group. The experimental group will receive text messages with guidance towards follow-up care with their PCP and the importance of the flu vaccine for children with asthma. The control group will receive a series of educational self-care and health based text messages unrelated to asthma or the flu vaccine. Some self-report of behaviors will be captured via text message response.

ANALYSIS Primary outcomes for the educational versus targeted text message groups will be compared use Chi-square tests. Additional adjustments may be applied for missing data or if, despite randomization, there is substantial imbalance between group in key covariates (eg race/ethnicity, insurance type or asthma severity.)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pediatrics Emergency Medicine Text messaging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Subjects receive general, health-related text messages applicable for children with asthma.

Group Type ACTIVE_COMPARATOR

General text messages

Intervention Type BEHAVIORAL

Subjects received text messages generalized to children with asthma

Test group

Subjects receive specific, targeted text messages for post-emergency department discharge asthma care.

Group Type EXPERIMENTAL

Targeted text messages

Intervention Type BEHAVIORAL

Subjects received text messages specific to post ED asthma follow-up

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Targeted text messages

Subjects received text messages specific to post ED asthma follow-up

Intervention Type BEHAVIORAL

General text messages

Subjects received text messages generalized to children with asthma

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Caregivers of patients aged 4 - 17 years (inclusive) will be eligible for study participation if they meet the following criteria:

1. Presentation to the ED with a chief complaint related to an asthma exacerbation such as shortness of breath, respiratory distress, wheezing, etc…
2. Receive an albuterol treatment in the ED
3. Previous history of asthma as represented in the medical record or by parental report
4. Have a cell phone that is able to receive text messages
5. Able to communicate and provide consent in English or Spanish

Exclusion Criteria

* Caregivers of patients will be excluded from this study for the following reasons:

1. First episode of wheezing
2. Admitted to the hospital
3. Co-morbid respiratory disease:

1. Cystic fibrosis
2. Bronchiectasis
3. Pulmonary hypertension
4. Other chronic lung disease
4. Current cancer diagnosis
5. Previous cardiovascular surgery
6. Inflammatory bowel disease
7. Sickle Cell disease
Minimum Eligible Age

4 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HealthPartners Institute

OTHER

Sponsor Role collaborator

Children's Hospitals and Clinics of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospitals and Clinics of Minnesota - Emergency Department

Minneapolis, Minnesota, United States

Site Status RECRUITING

Children's Minnesota

Saint Paul, Minnesota, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Heidi Vander Velden

Role: CONTACT

Phone: 6128137892

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Anupam B Kharbanda, MD

Role: primary

Anupam Kharbanda, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1409-082

Identifier Type: -

Identifier Source: org_study_id